Firefly Neuroscience Inc

Firefly Neuroscience Inc(AIFF)のニュースとイベント

$1.070

-0.039 (-3.60%)終値時点

AIFF のニュース

AIFF のイベント

9/25 08:30

Firefly Neuroscience Partners with NeuroSigma to Expand Access to Monarch eTNS System

Firefly Neuroscience and NeuroSigma announced a strategic partnership to expand clinician awareness of and access to NeuroSigma's Monarch eTNS System through Firefly's growing nationwide network of Evoke clinician customers. Under the partnership, Firefly will introduce the Monarch device to psychiatry, neurology and behavioral health practices that use its FDA 510(k)-cleared, AI-powered Evoke EEG/ERP platform.

7/28 09:30

Firefly Neuroscience and Next Health Announce Strategic Partnership

Firefly Neuroscience and Next Health, a global leader in health optimization and longevity, announced a strategic partnership to launch a precision cognitive health platform integrating Firefly's AI-powered, FDA-cleared EEG/ERP brain biomarker technology with personalized cognitive peptide protocols. The initiative aims to provide physicians with objective measures of brain function to help personalize, monitor, and optimize emerging cognitive therapies. The announcement follows last week's recommendation by an FDA Advisory Committee to add six therapeutic peptides, including Epitalon and Semax, to the list of bulk drug substances eligible for pharmacy compounding. The recommendation is not binding and requires further FDA action. The initiative is expected to leverage Next Health's expanding network of longevity clinics. The companies intend to collaborate on developing standardized clinical protocols integrating Firefly's FDA-cleared EEG/ERP platform with provider-guided peptide therapies.

5/20 08:10

Firefly Neuroscience Files to Sell 22.5M Shares of Common Stock

Firefly Neuroscience files to sell 22.5M shares of common stock for holders

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める